Literature DB >> 26408924

Structure-Function Relationship of the Interaction between Tissue Factor and Factor VIIa.

Joshua M Gajsiewicz1, James H Morrissey1.   

Abstract

Interactions between tissue factor and factor VIIa are the primary initiators of coagulation in hemostasis and certain thrombotic diseases. Tissue factor, an integral membrane protein expressed extensively outside of the vasculature, is the regulatory protein cofactor for coagulation factor VIIa. Factor VIIa, a trypsin-like serine protease homologous with other blood coagulation proteases, is weakly active when free in solution and must bind its membrane-bound cofactor for physiologically relevant activity. Tissue factor allosterically activates factor VIIa by several mechanisms such as active site positioning, spatial stabilization, and direct interactions with the substrate. Protein-membrane interactions between tissue factor, factor VIIa, and substrates all play critical roles in modulating the activity of this enzyme complex. Additionally, divalent cations such as Ca(2+) and Mg(2+) are critical for correct protein folding, as well as protein-membrane and protein-protein interactions. The contributions of these factors toward tissue factor-factor VIIa activity are discussed in this review. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26408924      PMCID: PMC4862872          DOI: 10.1055/s-0035-1564044

Source DB:  PubMed          Journal:  Semin Thromb Hemost        ISSN: 0094-6176            Impact factor:   4.180


  119 in total

Review 1.  Platelet membrane phospholipid asymmetry: from the characterization of a scramblase activity to the identification of an essential protein mutated in Scott syndrome.

Authors:  T Lhermusier; H Chap; B Payrastre
Journal:  J Thromb Haemost       Date:  2011-10       Impact factor: 5.824

2.  Activated factor VII: presence in factor IX concentrates and persistence in the circulation after infusion.

Authors:  U Seligsohn; C K Kasper; B Osterud; S I Rapaport
Journal:  Blood       Date:  1979-05       Impact factor: 22.113

3.  Coagulation factors VII and X induce Ca2+ oscillations in Madin-Darby canine kidney cells only when proteolytically active.

Authors:  E Camerer; J A Rottingen; J G Iversen; H Prydz
Journal:  J Biol Chem       Date:  1996-11-15       Impact factor: 5.157

4.  Influence of membrane composition on the enhancement of factor VIIa/tissue factor activity by magnesium ions.

Authors:  Narjes Tavoosi; James H Morrissey
Journal:  Thromb Haemost       Date:  2013-11-28       Impact factor: 5.249

5.  Importance of substrate composition, pH and other variables on tissue factor enhancement of factor VIIa activity.

Authors:  P F Neuenschwander; D E Branam; J H Morrissey
Journal:  Thromb Haemost       Date:  1993-12-20       Impact factor: 5.249

6.  An unusual antibody that blocks tissue factor/factor VIIa function by inhibiting cleavage only of macromolecular substrates.

Authors:  M M Fiore; P F Neuenschwander; J H Morrissey
Journal:  Blood       Date:  1992-12-15       Impact factor: 22.113

7.  FVIIa:TF induces cell survival via G12/G13-dependent Jak/STAT activation and BclXL production.

Authors:  Henri H Versteeg; C Arnold Spek; Sjoukje H Slofstra; Sander H Diks; Dick J Richel; Maikel P Peppelenbosch
Journal:  Circ Res       Date:  2004-03-11       Impact factor: 17.367

8.  The active site of factor IXa is located far above the membrane surface and its conformation is altered upon association with factor VIIIa. A fluorescence study.

Authors:  V P Mutucumarana; E J Duffy; P Lollar; A E Johnson
Journal:  J Biol Chem       Date:  1992-08-25       Impact factor: 5.157

9.  Ca2+ in the first epidermal growth factor-like domain of activated factor VII.

Authors:  E Persson; L S Nielsen
Journal:  Blood Coagul Fibrinolysis       Date:  1998-03       Impact factor: 1.276

10.  High affinity Ca(2+)-binding site in the serine protease domain of human factor VIIa and its role in tissue factor binding and development of catalytic activity.

Authors:  A K Sabharwal; J J Birktoft; J Gorka; P Wildgoose; L C Petersen; S P Bajaj
Journal:  J Biol Chem       Date:  1995-06-30       Impact factor: 5.157

View more
  13 in total

Review 1.  Nanodiscs in Membrane Biochemistry and Biophysics.

Authors:  Ilia G Denisov; Stephen G Sligar
Journal:  Chem Rev       Date:  2017-02-08       Impact factor: 60.622

2.  The evolution of factor XI and the kallikrein-kinin system.

Authors:  Michał B Ponczek; Aleksandr Shamanaev; Alec LaPlace; S Kent Dickeson; Priyanka Srivastava; Mao-Fu Sun; Andras Gruber; Christian Kastrup; Jonas Emsley; David Gailani
Journal:  Blood Adv       Date:  2020-12-22

3.  Subarachnoid hemorrhage - Induced block of cerebrospinal fluid flow: Role of brain coagulation factor III (tissue factor).

Authors:  Eugene V Golanov; Evgeniy I Bovshik; Kelvin K Wong; Robia G Pautler; Chase H Foster; Richard G Federley; Jonathan Y Zhang; James Mancuso; Stephen Tc Wong; Gavin W Britz
Journal:  J Cereb Blood Flow Metab       Date:  2017-03-28       Impact factor: 6.200

4.  Microfluidic platform for efficient Nanodisc assembly, membrane protein incorporation, and purification.

Authors:  James H Wade; Joshua D Jones; Ivan L Lenov; Colleen M Riordan; Stephen G Sligar; Ryan C Bailey
Journal:  Lab Chip       Date:  2017-08-22       Impact factor: 6.799

5.  Novel mutation in coagulation factor VII (Carmel mutation): Identification and characterization.

Authors:  Aliza Cassel; Nurit Rosenberg; Emad Muhammad; Tami Livnat; Rima Dardik; Miriam Berl; Meir Preis
Journal:  Res Pract Thromb Haemost       Date:  2021-02-25

6.  The procoagulant activity of tissue factor expressed on fibroblasts is increased by tissue factor-negative extracellular vesicles.

Authors:  Marcela Rosas; David A Slatter; Samya G Obaji; Jason P Webber; Jorge Alvarez-Jarreta; Christopher P Thomas; Maceler Aldrovandi; Victoria J Tyrrell; Peter V Jenkins; Valerie B O'Donnell; Peter W Collins
Journal:  PLoS One       Date:  2020-10-08       Impact factor: 3.240

Review 7.  Biochemical, molecular and clinical aspects of coagulation factor VII and its role in hemostasis and thrombosis.

Authors:  Francesco Bernardi; Guglielmo Mariani
Journal:  Haematologica       Date:  2021-02-01       Impact factor: 9.941

8.  A modified clot-based assay to measure negatively charged procoagulant phospholipids.

Authors:  Cathrine Ramberg; S Jamaly; N Latysheva; L Wilsgård; T Sovershaev; O Snir; J-B Hansen
Journal:  Sci Rep       Date:  2021-04-29       Impact factor: 4.379

9.  Bifunctional TGF-β trap/IL-15 protein complex elicits potent NK cell and CD8+ T cell immunity against solid tumors.

Authors:  Bai Liu; Xiaoyun Zhu; Lin Kong; Meng Wang; Catherine Spanoudis; Pallavi Chaturvedi; Varghese George; Jin-An Jiao; Lijing You; Jack O Egan; Christian Echeverri; Victor L Gallo; Jilan Xing; Kristine Ravelo; Caitlin Prendes; Julian Antolinez; Julia Denissova; Gabriela J Muniz; Emily K Jeng; Peter R Rhode; Hing C Wong
Journal:  Mol Ther       Date:  2021-06-04       Impact factor: 12.910

10.  Engineering of a membrane-triggered activity switch in coagulation factor VIIa.

Authors:  Anders L Nielsen; Anders B Sorensen; Heidi L Holmberg; Prafull S Gandhi; Johan Karlsson; Jens Buchardt; Kasper Lamberth; Mads Kjelgaard-Hansen; Carsten Dan Ley; Brit B Sørensen; Wolfram Ruf; Ole H Olsen; Henrik Østergaard
Journal:  Proc Natl Acad Sci U S A       Date:  2017-11-06       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.